| Literature DB >> 26270267 |
Francisco Boix-Giner1, Olga Millan2, David San Segundo3, Pedro Muñoz-Cacho4, Esther Mancebo5, Santiago Llorente6, Lourdes Rafael-Valdivia7, Antoni Rimola8, Emilio Fábrega9, Anna Mrowiec1, Luis Allende5, Alfredo Minguela10, Jose M Bolarín1, Estela Paz-Artal5, Marcos López-Hoyos3, Mercé Brunet2, Manuel Muro11.
Abstract
Several studies have analyzed the potential of T regulatory cells (Treg cells) as biomarkers of acute rejection (AR). The aim of the present multicenter study was to correlate the percentage of peripheral Treg cells in liver graft recipients drawn at baseline up to 12 months after transplantation with the presence of AR. The percentage of central memory (cm) Treg cells (CD4(+)CD25(high)CD45RO(+)CD62L(+)) was monitored at pre-transplant and at 1 and 2 weeks, and 1, 2, 3 and 6 months and 1 year post-transplantation. The same validation standard operating procedures were used in all participating centers. Fifteen patients developed AR (23.4%). Hepatitis C virus recurrence was observed in 16 recipients, who displayed low peripheral blood cmTreg levels compared with patients who did not. A steady increase of cmTregs was observed during the first month after transplantation with statistically significant differences between AR and non-AR patients. The high frequency of memory Treg cells allowed us to monitor rejection episodes during the first month post-transplantation. On the basis of these data, we developed a prediction model for assessing risk of AR that can provide clinicians with useful information for managing patients individually and customizing immunosuppressive therapies. © The Japanese Society for Immunology. 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.Entities:
Keywords: Treg; acute rejection; liver transplantation; receiver operating characteristic curves
Mesh:
Substances:
Year: 2015 PMID: 26270267 PMCID: PMC4885217 DOI: 10.1093/intimm/dxv048
Source DB: PubMed Journal: Int Immunol ISSN: 0953-8178 Impact factor: 4.823